Acute lymphoblastic leukemia: recent advances in biology and therapy.

PubWeight™: 1.65‹?› | Rank: Top 3%

🔗 View Article (PMID 2659098)

Published in Blood on June 01, 1989

Authors

R Champlin1, R P Gale

Author Affiliations

1: Department of Medicine, UCLA School of Medicine, Los Angeles, CA 90024-1678.

Articles by these authors

(truncated to the top 100)

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature (1985) 8.32

Graft-versus-leukemia reactions after bone marrow transplantation. Blood (1990) 7.11

IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol (1997) 4.52

Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell (1986) 3.59

Bone marrow transplantation after the Chernobyl nuclear accident. N Engl J Med (1989) 3.46

Cord-blood-cell transplantation--a real sleeper? N Engl J Med (1995) 3.29

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol (1990) 3.19

Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood (1994) 2.93

Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79

Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65

Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med (1983) 2.53

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann Intern Med (1996) 2.52

Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood (2000) 2.40

Clinical uses of intravenous immunoglobulins. Ann Intern Med (1990) 2.29

Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood (1976) 2.29

T-cell depletion of HLA-identical transplants in leukemia. Blood (1991) 2.25

Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc Natl Acad Sci U S A (1993) 2.12

Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood (1993) 2.12

Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia. Ann Intern Med (1980) 2.11

Is there a T-cell form of chronic lymphocytic leukemia? Leukemia (1992) 2.08

What's new in blood progenitor cell autotransplants? Bone Marrow Transplant (1994) 1.98

Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity. J Immunol (1975) 1.98

Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood (1990) 1.98

Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res (1993) 1.89

A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood (1979) 1.83

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Bone Marrow Transplant (2011) 1.82

High remission-induction rate in acute myeloid leukaemia. Lancet (1977) 1.78

Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? Blood (1992) 1.77

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol (1997) 1.75

Infectious complications of human bone marrow transplantation. Medicine (Baltimore) (1979) 1.74

Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med (1982) 1.74

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med (1988) 1.73

Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA (1993) 1.70

Surface markers on leukemia and lymphoma cells: recent advances. Blood (1982) 1.69

Chronic graft versus host disease: a syndrome of disordered immunity. Am J Med (1979) 1.65

Age of onset and type of leukaemia. Lancet (1989) 1.64

Bone-marrow transplantation for leukaemia. Lancet (1995) 1.60

p53 in chronic myelogenous leukemia in acute phase. Proc Natl Acad Sci U S A (1991) 1.56

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant (2004) 1.55

Bone marrow origin of hepatic macrophages (Kupffer cells) in humans. Science (1978) 1.53

Modulation of polymorphonuclear leukocyte-mediated antibody-dependent cellular cytotoxicity. J Immunol (1974) 1.51

An 8-kilobase abl RNA transcript in chronic myelogenous leukemia. Proc Natl Acad Sci U S A (1984) 1.51

Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. JAMA (1999) 1.49

Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med (1987) 1.48

Altered transcription of an oncogene in chronic myeloid leukaemia. Lancet (1984) 1.46

Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood (1989) 1.46

The role of T-cells in preventing relapse in chronic myelogenous leukemia. Bone Marrow Transplant (1987) 1.45

Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med (1980) 1.44

Bone marrow transplantation for Fanconi anemia. Blood (1995) 1.42

A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature (1987) 1.42

Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med (1986) 1.42

Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med (1997) 1.41

'A rose by any other name would smell as sweet', or would it? Bone Marrow Transplant (2013) 1.41

How best to analyse new strategies in bone marrow transplantation. Bone Marrow Transplant (1990) 1.39

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol (2000) 1.36

Immediate medical consequences of nuclear accidents. Lessons from Chernobyl. JAMA (1987) 1.35

Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood (2001) 1.34

Origin of human bone marrow fibroblasts. Br J Haematol (1980) 1.34

Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav Immun (1991) 1.34

Allogeneic bone marrow transplantation for low-grade lymphoma. Blood (1998) 1.29

Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science (1984) 1.26

MPN-associated myelofibrosis (MPN-MF). Leuk Res (2010) 1.25

Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. Bone Marrow Transplant (1998) 1.25

Pneumococcal infections after human bone-marrow transplantation. Ann Intern Med (1979) 1.23

Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transplant (1991) 1.23

Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. J Clin Oncol (1996) 1.22

Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients. Am J Med (1984) 1.21

bcr genes and transcripts. Oncogene (1988) 1.19

How does bone-marrow transplantation cure leukaemia? Lancet (1984) 1.19

Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood (1992) 1.19

T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood (2000) 1.19

Cytomegalovirus immune plasma in bone marrow transplant recipients. Ann Intern Med (1982) 1.18

Chronic lymphocytic leukemia: new insights into biology and therapy. Ann Intern Med (1990) 1.17

A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med (1981) 1.17

Nucleotide sequence analysis of human abl and bcr-abl cDNAs. Oncogene (1989) 1.16

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Bone Marrow Transplant (2001) 1.16

Chronic lymphocytic leukemia. Recent advances in biology and treatment. Ann Intern Med (1985) 1.16

Hematopoietic recovery after 10-Gy acute total body radiation. Blood (1994) 1.16

Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene (1992) 1.15

Genetic relatedness of lymphoid malignancies. Transformation of chronic lymphocytic leukemia as a model. Ann Intern Med (1993) 1.13

Graft-versus-host disease. Immunol Rev (1985) 1.13

Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. Br J Haematol (1999) 1.13

Acute myelogenous leukemia: recent advances in therapy. Blood (1987) 1.11

In vitro hepatitis B virus infection of human bone marrow cells. J Clin Invest (1986) 1.11

Chemotherapy versus transplantation: I. Acute myelogenous leukemia. Haematologica (1989) 1.10

Are new conditioning regimens for transplants in acute myelogenous leukemia better? Bone Marrow Transplant (1991) 1.08

Graft-versus-leukemia following bone marrow transplantation. Bone Marrow Transplant (1987) 1.08

bcr-abl RNA in patients with chronic myelogenous leukemia. Blood (1987) 1.07

Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood (1992) 1.07

Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. Am J Med (1986) 1.07

Advances in the treatment of acute myelogenous leukemia. N Engl J Med (1979) 1.07

Graft rejection and graft-versus-host disease: mirror images. Lancet (1986) 1.07

Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants. Ann Intern Med (1988) 1.06

Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation. Ann Intern Med (1985) 1.06

Aplastic anemia and non-A, non-B hepatitis. Am J Med (1983) 1.06

Chemotherapy versus transplantation: II. Acute lymphoblastic leukemia. Haematologica (1989) 1.06

Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med (1983) 1.06

Designed transfer of specific immune responses with bone marrow transplantation. J Clin Invest (1986) 1.05

Factors associated with interstitial pneumonitis after bone-marrow transplantation for acute leukaemia. Lancet (1982) 1.05

T cell depletion in bone marrow transplantation for leukemia: current results and future directions. Bone Marrow Transplant (1988) 1.04